German Aerospace & Defense Stock News

XTRA:NDA
XTRA:NDAMetals and Mining

Aurubis (XTRA:NDA) Valuation Check After Upgraded 2025–26 Earnings Guidance And Stronger Copper Trends

Why Aurubis stock is back on investors’ radar Aurubis (XTRA:NDA) has drawn fresh attention after raising its 2025–26 operating EBT guidance to €375 million to €475 million. This follows a first quarter with higher sales and net income versus a year earlier. See our latest analysis for Aurubis. The raised guidance and strong first quarter have coincided with a sharp move in the stock, with a 30.35% year to date share price return and a 102.07% total shareholder return over the past year...
XTRA:EVK
XTRA:EVKChemicals

Evaluating Evonik Industries (XTRA:EVK) Valuation After Annual Results And Dividend Confirmation

What the latest earnings and dividend mean for Evonik Industries (XTRA:EVK) Evonik Industries (XTRA:EVK) reported full year 2025 results with sales of €14,069 million and net income of €634 million, alongside confirming an annual dividend of €1.00 per share payable in June 2026. See our latest analysis for Evonik Industries. The release of full year 2025 results, which showed sales of €14.1b and net income of €634 million, appears to be in focus for investors. The 7 day share price return of...
XTRA:AT1
XTRA:AT1Real Estate

A Look At Aroundtown (XTRA:AT1) Valuation As New Bond Issuances Reshape Its Capital Structure

Why Aroundtown’s latest bond issuances matter for equity investors Aroundtown (XTRA:AT1) has been active in the debt markets recently, completing several transactions that reshape how it finances its real estate portfolio and manage upcoming obligations. On 30 January 2026, the company issued two senior unsecured bond series in Australia, each sized at A$300 million, with maturities of 5 and 10 years. Investor demand was strong, with the combined orderbook reportedly above A$1.9 billion, and...
XTRA:SRT3
XTRA:SRT3Life Sciences

Sartorius Q4 Margin Miss Shifts Focus To Earnings Quality And Mix

Sartorius (XTRA:SRT3) reported Q4 results that missed expectations, with pressure on margins. Management issued cautious guidance, highlighting a focus on margin recovery. The company plans to prioritize higher value product rollouts as part of its response. These updates signal a potential inflection point in how Sartorius balances growth, profitability, and product mix. Sartorius, a supplier of equipment and solutions for the biopharma and life sciences industry, operates within long term...
XTRA:SIE
XTRA:SIEIndustrials

Siemens (XTRA:SIE) Valuation In Focus After Canopus AI Semiconductor Metrology Acquisition

Canopus AI deal puts Siemens’ semiconductor ambitions in focus Siemens (XTRA:SIE) is drawing fresh attention after acquiring Canopus AI, a specialist in AI-driven metrology tools for semiconductor production. The move ties the group more closely to advanced chip manufacturing workflows. See our latest analysis for Siemens. At a current share price of €250.5, Siemens has a 1 day share price return of 2.45% that comes after a softer 7 day share price return of 2.26% and a fairly muted 30 day...
XTRA:AIXA
XTRA:AIXASemiconductor

Assessing AIXTRON (XTRA:AIXA) Valuation As AI Tool Demand Builds Ahead Of Earnings

AIXTRON (XTRA:AIXA) heads into its 26 February 2026 earnings report with attention on how AI related demand for GaN and SiC tools is feeding through to orders and guidance. See our latest analysis for AIXTRON. At a share price of €20.32, AIXTRON has seen a 23.15% 90 day share price return and a 54.77% 1 year total shareholder return. This suggests that optimism around AI exposed GaN and SiC tools has been building ahead of the earnings update. If AI exposed equipment suppliers are on your...